1.Effect of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis
Shuming HE ; Mingxiu WEI ; Yanhua HAN ; Lihong HE
Chinese Journal of Obstetrics and Gynecology 2001;0(08):-
Objective To assess the clinical efficacy of levonorgestrel-releasing intrauterine system(LNG-IUS) in the treatment of adenomyosis. Methods Forty-two patients with adenomyosis diagnosed by clinical symptoms, MRI, laparoscopy and/or chromatic colour type-B ultrasound were treated with LNG-IUS, and the menstrual blood volume, severity of dysmenorrhea and uterine volume were observed three months later. Results After 3 month treatment of LNG-IUS, the menstrual blood volume reduced significantly to (27?11)% of that before treatment. The uterine volume was decreased from (143?33) cm 3 to (115?22) cm 3( P
2.Measurement of urine riboflavin in patients with diabetes mellitus
Jian WANG ; Mingxiu LI ; Jing XU ; Wei CHEN ;
Parenteral & Enteral Nutrition 1997;0(02):-
Objectives:To investigate the metabolism of riboflavin in type 2 of diabetes mellitus(DM) patient. Methods:The content of riboflavin in the urine in type 2 of DM patient was detected and the complication related to DM was examined. Results:The average content of urine riboflavin in DM patients was lower than that of normal people, and the prevalence rate of cataract, hypertension and coronary heart disease was higher in the low content group of urine riboflavin than that in the normal group( P
3. Clinical value of HE4,CA125 and ROMA in diagnosis of ovarian epithelial malignant tumor
Lin LIN ; Mingxiu JU ; Zhi-wei QIAO ; Rui TONG ; Chun-yan WANG
Chinese Journal of Practical Gynecology and Obstetrics 2019;35(12):1384-1387
OBJECTIVE: To investigate the value of HE4,CA125 and ovarian malignant tumor risk prediction models(ROMA)in the diagnosis of ovarian epithelial malignant tumors.METHODS: The clinical and pathological data of 247 patients with ovarian tumors(EOC 139 cases,BOT 18 cases,and benign ovarian tumor 90 cases)and 39 patients with uterine fibroids in Liaoning Tumor Hospital from September 2016 to August 2017 were retrospectively analyzed. The levels of serum CA125 and HE4 were measured before operation. The ROMA values were calculated and the relationship between CA125,HE4,ROMA values and clinical pathological parameters were analyzed. The diagnostic evaluation index was calculated,the receiver operating characteristic(ROC)curve was drawn,and the AUC value was also calculated.RESULTS: The positive rate of HE4 in the ovarian epithelial malignant tumor group was significantly higher than that in other groups before and after menopause,the difference being statistically significant(P<0.05).The positive rate of CA125 in the group of malignant epithelial tumor of ovary was significantly higher than that in other groups after menopause,the difference being statistically significant(P<0.05),but there was no statistical difference before menopause(P>0.05).There was no significant statistical difference in the positive rate of ROMA before or after menopause(P>0.05).The sensitivity of CA125 was higher than that of HE4 and ROMA. Specificity of HE4 was higher than that of CA125 and ROMA.Correct diagnosis index of ROMA was higher than that of HE4 and CA125.CONCLUSION: For the diagnosis of ovarian malignant epithelial tumors,the combined detection of serum HE4 and CA125 and ROMA model is superior to the individual detection of HE4 and CA125.